Related Experiment Videos
The effects of hormone replacement therapy on coronary heart disease
1Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, USA.
Insights
Cardiovascular disease is a leading cause of death in women. Current evidence indicates that hormone replacement therapy (HRT) is not yet a proven strategy for preventing coronary heart disease (CHD).
Area of Science:
- Cardiology
- Women's Health
- Endocrinology
Background:
- Cardiovascular disease (CVD) is a significant cause of morbidity and mortality among women in the United States.
- Coronary heart disease (CHD) specifically accounts for a substantial proportion of these CVD-related deaths in women.
Purpose of the Study:
- To review current evidence regarding the efficacy of hormone replacement therapy (HRT) in preventing coronary heart disease (CHD) in women.
- To assess whether existing data support the recommendation of HRT as a primary prevention strategy for CHD.
Main Methods:
- Literature review of existing clinical studies and evidence on hormone replacement therapy and cardiovascular outcomes in women.
- Analysis of data focusing on the relationship between HRT and the incidence of coronary heart disease.
Main Results:
- Current evidence suggests that hormone replacement therapy (HRT) has not been definitively proven as a preventive strategy for coronary heart disease (CHD).
- The data available indicate that it is premature to recommend HRT for CHD prevention in women based on existing research.
Conclusions:
- Hormone replacement therapy (HRT) is not currently supported by robust evidence as a proven method for preventing coronary heart disease (CHD) in women.
- Further research is needed to clarify the role, if any, of HRT in cardiovascular disease prevention strategies for women.
Abstract:
The importance of cardiovascular disease as a cause of morbidity and mortality in women is well appreciated. Cardiovascular disease accounts for approximately 48% of deaths in women in the United States. In particular, coronary heart disease (CHD) accounts for approximately one-half of these deaths. This article describes current evidence that suggests it is premature to recommend hormone replacement therapy (HRT) as a proven prevention strategy for CHD.